
Geron Corporation GERN
$ 1.48
-4.84%
Annual report 2025
added 03-02-2026
Geron Corporation Total Inventories 2011-2026 | GERN
Annual Total Inventories Geron Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117 M | 38.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 117 M | 38.7 M | 77.7 M |
Quarterly Total Inventories Geron Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95.4 M | 69.1 M | 56.2 M | 20.3 M | 774 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 95.4 M | 774 K | 48.4 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apellis Pharmaceuticals
APLS
|
143 M | $ 20.41 | -1.4 % | $ 2.57 B | ||
|
Aptorum Group Limited
APM
|
39.1 K | $ 0.79 | -6.51 % | $ 4.31 M | ||
|
Axsome Therapeutics
AXSM
|
27.9 M | $ 165.07 | -0.79 % | $ 8.21 B | ||
|
AbCellera Biologics
ABCL
|
6.34 M | $ 3.76 | -1.7 % | $ 1.12 B | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Codexis
CDXS
|
1.8 M | $ 1.01 | -0.98 % | $ 74.1 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
37.2 M | $ 23.77 | -0.46 % | $ 2.91 B | ||
|
Agenus
AGEN
|
55.5 K | $ 3.27 | -2.09 % | $ 1.17 M | ||
|
Agios Pharmaceuticals
AGIO
|
32.9 M | $ 28.85 | -1.2 % | $ 1.67 B | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Amarin Corporation plc
AMRN
|
196 M | $ 14.3 | 2.66 % | $ 5.93 B | ||
|
AbbVie
ABBV
|
4.95 B | $ 233.44 | -0.33 % | $ 413 B |